Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 71,065 Grace Therapeutics, Inc. shares (Form 4)

Traded Oct 14 to Oct 16, 2026 · Filed Oct 16, 2026

From Oct 14 to Oct 16, 2026, Opaleye Management Inc. (10% owner) bought 71,065 Grace Therapeutics, Inc. shares at an average US$1.92 for US$136K, leaving 2,944,354 shares. Filed Oct 16, 2026 (Form 4).

Bought
71,065 shares
Price
US$1.92 average (US$1.89 to US$1.95)
Value
US$136K
Holding after
2,944,354 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 14, 2026Common Stock, par value $0.0001 per shareBuy11,233US$1.932,884,522Indirect
Oct 15, 2026Common Stock, par value $0.0001 per shareBuy23,485US$1.952,908,007Indirect
Oct 16, 2026Common Stock, par value $0.0001 per shareBuy36,347US$1.892,944,354Indirect

Source

Download original · View original at SEC

Related